Legal status · United States
Is Mitochondrial+ blend legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Mitochondrial+ blend is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 1 human study is cited on its profile.
Mitochondrial+ blend in the United States at a glance
| Classification | Not approved; research use only |
|---|---|
| Note | Sold research use only by peptide vendors. Elamipretide is investigational; the other two have no clinical development programme. |
| FDA approval status | Not approved. None of the three components holds a marketing authorisation and no regulator has evaluated the combination. |
| Human studies cited | 1 of 4 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Mitochondrial+ blend profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
No product containing Mitochondrial+ blend is approved by FDA for any use in the United States, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in the United States. This page is general information, not legal advice.
What Mitochondrial+ blend is
A 55 mg three-peptide vial, sold at 9 mg SS-31, 16 mg TB-500 and 30 mg MOTS-c. MOTS-c is more than half the powder and has no human trial; the SS-31 component with an actual phase 3 programme is the smallest share at 16.4%; and the third component is a repair peptide with no mitochondrial rationale at all.
This vial is the clearest case in the batch of the arithmetic changing what the product is. The split is 9 mg SS-31, 16 mg TB-500 and 30 mg MOTS-c, 55 mg of powder.
Mechanism: SS-31 binds cardiolipin in the inner mitochondrial membrane and is described as stabilising it. MOTS-c is a mitochondrially encoded peptide described as activating AMPK.
Regulatory history: Not approved. None of the three components holds a marketing authorisation and no regulator has evaluated the combination.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Mitochondrial+ blend at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Mitochondrial+ blend in other countries
Frequently asked questions
Is Mitochondrial+ blend legal in the United States?
No. Mitochondrial+ blend is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 1 human study is cited on its profile. Note: Sold research use only by peptide vendors. Elamipretide is investigational; the other two have no clinical development programme.
Can I buy Mitochondrial+ blend in the United States?
No approved product exists to buy. In the United States Mitochondrial+ blend is classified as "Not approved; research use only", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: Sold research use only by peptide vendors. Elamipretide is investigational; the other two have no clinical development programme.
Is Mitochondrial+ blend FDA approved?
No. FDA status: Not approved. None of the three components holds a marketing authorisation and no regulator has evaluated the combination.. Current US classification: "Not approved; research use only". On the evidence, 1 human study is cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Mitochondrial+ blend live on its compound profile.
Mitochondrial+ blend profileThis page is general information about the regulatory status of Mitochondrial+ blend in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.